According to the news on the website of the National Development and Reform Commission on the 10th, the National Development and Reform Commission issued a notice on printing and distributing the "14th Five-Year Plan for Bio-Economy Development Plan", which involved many aspects of automatic cell preparation and cell therapy. This article intercepts relevant content for your reference only.

　　(九)Promote the development of the medical and health industry.

　　Improve the level of clinical care. Develop advanced technologies such as microfluidic chips and cell preparation automation, promote the development of biopharmaceuticals such as antibody drugs, recombinant proteins, peptides, cell and gene therapy products, and encourage the promotion of original research on major diseases and rare diseases such as chronic diseases, tumors, and neurodegenerative diseases Drug Discovery. Expand the clinical application of advanced treatment technologies such as intelligent surgical robots and digital therapy particle radiotherapy. Formulate and improve technical specifications for stem cell therapy, cellular immunotherapy, and new medical technologies for clinical application, and scientifically carry out clinical evaluation.

　　Formulate and improve technical specifications for stem cell therapy, cellular immunotherapy, and new medical technologies for clinical application, and scientifically carry out clinical evaluation.

　　(二十五)Promote policies to try first.

　　Make good use of the Yangtze River Delta and the Guangdong-Hong Kong-Macao Greater Bay Area drug and medical device technology review and inspection sub-centers, and encourage reform pilots in the fields of cell therapy, traditional Chinese medicine and traditional Chinese medical device registration supervision relying on the Free Trade Pilot Zone and Hainan Free Trade Port. Combining the construction of bio-economy innovation and development highlands and a new round of comprehensive innovation and reform experiments, select cities with good industrial foundations, active market entities, and strong radiation drive, build a number of bio-economy pilot areas, and first try technological innovation, access and supervision, and market Reform measures for key links in the field of bioeconomy, such as application, financial innovation, price, and foreign cooperation, fully gather high-level innovation resources at home and abroad, and encourage the development of new technologies, new industries, new formats, and new models.

　　(五)Accelerate the improvement of biotechnology innovation capabilities.

　　Develop new technologies such as gene diagnosis and treatment, stem cell therapy, and immune cell therapy, strengthen industry-university-research collaboration, accelerate the transformation and clinical application of related technology products, and promote the formation of new models of regenerative medicine and precision medicine.

   Bio-economy Innovation Capability Improvement Project

　Construct quality and safety evaluation technology platforms for antibody drugs, fusion protein drugs, biosimilar drugs, stem cell and cellular immunotherapy products, gene therapy products, exosome therapy products, and traditional Chinese medicine.

　　Screenshot of related files